VoxNeuro

Breakthrough brain assessment measures neuromarkers to reliably inform brain health management -General Health, ageing population, concussion, stroke, COVID-19.

  • Stage Product In Market
  • Industry Healthcare Services
  • Location Hamilton, ON, Canada
  • Currency CAD
  • Founded August 2017
  • Employees 10
  • Incorporation Type C-corp
  • Website voxneuro.com

Company Summary

VoxNeuro’s Cognitive Health Assessment™ is the first assessment in the world that reliably measures all core brain functions. These functions reflect mental abilities that allow us to live healthy, independent lives, like memory, concentration, and decision making. The breakthrough EEG-based neuroimaging assessment differentiates between true cognitive decline and perceived decline caused by situational factors like stress, fatigue or mood.

Team

  • James Connolly
    Co-founder, Chief Executive Officer

    Expertise in commercial development, client development, digital advertising, operations and sales.

  • John Connolly
    Co-founder, Chief Science Officer

    World-renowned neuroscientist with over 40 years of functional brain research supported by over $8M in funding, resulting in 300+ peer-reviewed scientific reports supporting VoxNeuro's foundational scientific breakthrough.

  • Kimberly Elliott
    Co-founder, Chief Operating Officer

    Expertise in operations, client service, HR, communications, strategy, project/budget management.

  • Sam Chebib
    Chief Strategist & Chairman of the Board

    Former Founder, President and CEO of Nightingale. Under his guidance the company became a cloud-based EHR leader in North America (#1 on Deloitte Fast 50 in Canada, #10 on Deloitte Fast 500 North America). Nightingale was acquired by Telus Health in 2016.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free